These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34122497)

  • 1. METTL14 Acts as a Potential Regulator of Tumor Immune and Progression in Clear Cell Renal Cell Carcinoma.
    Xu T; Gao S; Ruan H; Liu J; Liu Y; Liu D; Tong J; Shi J; Yang H; Chen K; Zhang X
    Front Genet; 2021; 12():609174. PubMed ID: 34122497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
    Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
    Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of m
    Wang J; Zhang C; He W; Gou X
    Front Oncol; 2020; 10():3. PubMed ID: 32038982
    [No Abstract]   [Full Text] [Related]  

  • 4. Expression profiles of m6A RNA methylation regulators, PD-L1 and immune infiltrates in gastric cancer.
    Xu Z; Chen Q; Shu L; Zhang C; Liu W; Wang P
    Front Oncol; 2022; 12():970367. PubMed ID: 36003776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma.
    Zhang QJ; Luan JC; Song LB; Cong R; Ji CJ; Zhou X; Xia JD; Song NH
    Exp Cell Res; 2020 Jul; 392(1):112015. PubMed ID: 32333907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression Pattern and Clinical Value of Key m6A RNA Modification Regulators in Abdominal Aortic Aneurysm.
    Li T; Wang T; Jing J; Sun L
    J Inflamm Res; 2021; 14():4245-4258. PubMed ID: 34511965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer.
    Gong PJ; Shao YC; Yang Y; Song WJ; He X; Zeng YF; Huang SR; Wei L; Zhang JW
    Front Oncol; 2020; 10():578963. PubMed ID: 33363011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. M6A "Writer" Gene
    Cai C; Long J; Huang Q; Han Y; Peng Y; Guo C; Liu S; Chen Y; Shen E; Long K; Wang X; Yu J; Shen H; Zeng S
    Front Oncol; 2021; 11():615296. PubMed ID: 34221955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. METTL14-mediated Lnc-LSG1 m6A modification inhibits clear cell renal cell carcinoma metastasis via regulating ESRP2 ubiquitination.
    Shen D; Ding L; Lu Z; Wang R; Yu C; Wang H; Zheng Q; Wang X; Xu W; Yu H; Xu L; Wang M; Yu S; Zhu S; Qian J; Xia L; Li G
    Mol Ther Nucleic Acids; 2022 Mar; 27():547-561. PubMed ID: 35036065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspase 4 Overexpression as a Prognostic Marker in Clear Cell Renal Cell Carcinoma: A Study Based on the Cancer Genome Atlas Data Mining.
    Meng L; Tian Z; Long X; Diao T; Hu M; Wang M; Zhang W; Zhang Y; Wang J; He Y
    Front Genet; 2020; 11():600248. PubMed ID: 33584797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of METTL14 in Kidney Renal Clear Cell Carcinoma Using Bioinformatics Analysis.
    Wang Q; Zhang H; Chen Q; Wan Z; Gao X; Qian W
    Dis Markers; 2019; 2019():5648783. PubMed ID: 31976022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMP9 and IGFBP1 Regulate Tumor Immune and Drive Tumor Progression in Clear Cell Renal Cell Carcinoma.
    Xu T; Gao S; Liu J; Huang Y; Chen K; Zhang X
    J Cancer; 2021; 12(8):2243-2257. PubMed ID: 33758602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated m6A-Related Regulators Are Associated With Tumor Metastasis and Poor Prognosis in Osteosarcoma.
    Li J; Rao B; Yang J; Liu L; Huang M; Liu X; Cui G; Li C; Han Q; Yang H; Cui X; Sun R
    Front Oncol; 2020; 10():769. PubMed ID: 32582536
    [No Abstract]   [Full Text] [Related]  

  • 15. Succinylation Regulators Promote Clear Cell Renal Cell Carcinoma by Immune Regulation and RNA N6-Methyladenosine Methylation.
    Lu W; Che X; Qu X; Zheng C; Yang X; Bao B; Li Z; Wang D; Jin Y; Wang Y; Xiao J; Qi J; Liu Y
    Front Cell Dev Biol; 2021; 9():622198. PubMed ID: 33681201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a m
    Zhao X; Cui L
    Am J Cancer Res; 2019; 9(10):2156-2169. PubMed ID: 31720080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of biomarkers related to CD8
    Lin J; Yu M; Xu X; Wang Y; Xing H; An J; Yang J; Tang C; Sun D; Zhu Y
    Aging (Albany NY); 2020 Feb; 12(4):3694-3712. PubMed ID: 32081834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of YTHDF2 in Clear Cell Renal Cell Carcinoma.
    Mu Z; Dong D; Sun M; Li L; Wei N; Hu B
    Front Oncol; 2020; 10():1566. PubMed ID: 33102202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL14-dependent m6A regulates vascular calcification induced by indoxyl sulfate.
    Chen J; Ning Y; Zhang H; Song N; Gu Y; Shi Y; Cai J; Ding X; Zhang X
    Life Sci; 2019 Dec; 239():117034. PubMed ID: 31697949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.